Itsbob

https://pubmed.ncbi.nlm.nih.gov
Abstract Background Afamitresgene autoleucel afami cel showed acceptable safety and promising efficacy in a phase 1 trial

https://www.adaptimmune.com › ...
The article titled SPEARHEAD 1 a single arm phase 2 trial of afamitresgene autoleucel afami cel in advanced

https://www.thelancet.com › journals › lancet › artic…
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma SPEARHEAD 1 an international

https://www.sciencedirect.com › science › article › pii
Afamitresgene autoleucel afami cel an autologous T cell receptor T cell therapy targets melanoma associated

https://www.fda.gov › drugs › resources-information...
To verify the clinical benefit of afamitresgene autoleucel the FDA and the sponsor agreed upon a postmarketing requirement for an

https://www.targetedonc.com › view › fda-grants-full...
The FDA has granted full approval of afamitresgene autoleucel Tecelra afami cel and expanded its indication to

https://www.esmoopen.com › article › fulltext
Afamitresgene autoleucel afami cel is an autologous engineered T cell receptor T cell therapy targeting tumors expressing

https://discovery.ucl.ac.uk › id › eprint
Abstract BACKGROUND Afamitresgene autoleucel afami cel showed acceptable safety and promising efficacy in a phase 1 trial

https://www.onclive.com › view › afamitresgene...
SPEARHEAD 1 is an open label non randomized study that enrolled patients with advanced synovial sarcoma or